Salivary biochemical parameters in people living with HIV on ART and dental caries: a cross-sectional study in Monastir, Tunisia.
Antiretroviral Therapy
Cross-sectional Study
Dental Caries
HIV/AIDS
Saliva
Tunisia
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
06 Jan 2024
06 Jan 2024
Historique:
received:
30
09
2023
accepted:
22
12
2023
medline:
7
1
2024
pubmed:
7
1
2024
entrez:
6
1
2024
Statut:
epublish
Résumé
Studies regarding salivary biochemical parameters and dental caries in adult people living with HIV/AIDS (PLWHA) are scanty. To investigate salivary biochemical parameters and dental caries in adult PLWHA who are on antiretroviral therapy (ART) and compare the findings with people negative for HIV infection. The study included 50 HIV positive individuals as a test group (TG) and 50 HIV negative individuals as a control group (CG). Dental examination was performed according to WHO guidelines to assess DMFT. Digital panoramic radiographs were taken to detect additional infectious foci. Non-stimulated saliva was collected between 9 and 12 a. m for 5 min to evaluate 18 biochemical parameters and salivary flow rate (SFR). Parametric and non parametric tests were used according to data distribution. The level of significance was set at p < 0.05%. Patients' mean ages and M/F sex ratios for TG and CG were 38.80 ± 9.69 y/o. vs. 37.98 ± 13.47 y/o. and 3.54 vs. 2.33, respectively. Higher means of decayed teeth were recorded in TG, 4.47 ± 3.00 vs. 3.88 ± 2.81 in CG with no significant difference (p = 0.41). Means of filled teeth were significantly lower in TG 2.38 ± 2.16 vs. 4.16 ± 3.35 in CG (p = 0.01), respectively. No statistical significant difference was noted in DMFT indices between the 2 groups (8.04 ± 6.90 vs. 8.52 ± 6.24, p = 0.71). The following salivary parameters were significantly lower in TG compared to CG, respectively: mean SFR 0.44 ± 0.18 ml/min vs. 0.61 ± 0.26 ml/min; median levels of sodium and chlorides, 4 mmol/L and 13.5 mmol/L vs. 9 mmol/L and 19 mmol/L (p < 0.001) and uric acid, 103.50 mmol/L vs. 163 (p = 0.009). However, higher median levels were recorded with calcium, 1.09 mmol/L vs. 0.54 (p < 0.001) and sIgA 23 mg/dl vs. 5 mg/dl (p < 0.001). In TG, a positive correlation was found between DC, potassium, urea, and chlorides (p < 0.05). Salivary renal and hepatic biomarkers were comparable between the two groups. PLWHA have shown an alteration in some salivary parameters, more decayed teeth and less filled teeth. Preventive measures should be implemented to lower dental caries and enhance accessibility to oral care services. In addition, saliva can be utilized to monitor oral and general health status among PLWHA on ART.
Sections du résumé
BACKGROUND
BACKGROUND
Studies regarding salivary biochemical parameters and dental caries in adult people living with HIV/AIDS (PLWHA) are scanty.
AIM
OBJECTIVE
To investigate salivary biochemical parameters and dental caries in adult PLWHA who are on antiretroviral therapy (ART) and compare the findings with people negative for HIV infection.
METHODS
METHODS
The study included 50 HIV positive individuals as a test group (TG) and 50 HIV negative individuals as a control group (CG). Dental examination was performed according to WHO guidelines to assess DMFT. Digital panoramic radiographs were taken to detect additional infectious foci. Non-stimulated saliva was collected between 9 and 12 a. m for 5 min to evaluate 18 biochemical parameters and salivary flow rate (SFR). Parametric and non parametric tests were used according to data distribution. The level of significance was set at p < 0.05%.
RESULTS
RESULTS
Patients' mean ages and M/F sex ratios for TG and CG were 38.80 ± 9.69 y/o. vs. 37.98 ± 13.47 y/o. and 3.54 vs. 2.33, respectively. Higher means of decayed teeth were recorded in TG, 4.47 ± 3.00 vs. 3.88 ± 2.81 in CG with no significant difference (p = 0.41). Means of filled teeth were significantly lower in TG 2.38 ± 2.16 vs. 4.16 ± 3.35 in CG (p = 0.01), respectively. No statistical significant difference was noted in DMFT indices between the 2 groups (8.04 ± 6.90 vs. 8.52 ± 6.24, p = 0.71). The following salivary parameters were significantly lower in TG compared to CG, respectively: mean SFR 0.44 ± 0.18 ml/min vs. 0.61 ± 0.26 ml/min; median levels of sodium and chlorides, 4 mmol/L and 13.5 mmol/L vs. 9 mmol/L and 19 mmol/L (p < 0.001) and uric acid, 103.50 mmol/L vs. 163 (p = 0.009). However, higher median levels were recorded with calcium, 1.09 mmol/L vs. 0.54 (p < 0.001) and sIgA 23 mg/dl vs. 5 mg/dl (p < 0.001). In TG, a positive correlation was found between DC, potassium, urea, and chlorides (p < 0.05). Salivary renal and hepatic biomarkers were comparable between the two groups.
CONCLUSIONS
CONCLUSIONS
PLWHA have shown an alteration in some salivary parameters, more decayed teeth and less filled teeth. Preventive measures should be implemented to lower dental caries and enhance accessibility to oral care services. In addition, saliva can be utilized to monitor oral and general health status among PLWHA on ART.
Identifiants
pubmed: 38184520
doi: 10.1186/s12903-023-03821-2
pii: 10.1186/s12903-023-03821-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
35Informations de copyright
© 2023. The Author(s).
Références
UNAIDS Global AIDS Update 2022. Geneva: Joint United Nations Programme on HIV/ AIDS; 2022. In danger: Licence: CC BY-NC-SA 3.0 IGO. Available at: https://www.unaids.org/sites/default/files/media_asset/2022-global-aids-update-summary_en.pdf .
UNAIDS Data 2023. Available at: https://www.unaids.org/en/resources/fact-sheet .
Shakiba E, Ramazani U, Mardani E, Rahimi Z, Nazar ZM, Najafi F, et al. Epidemiological features of HIV/AIDS in the Middle East and North Africa from 1990 to 2017. Int J STD AIDS. 2021;32(3):257–65.
doi: 10.1177/0956462420960632
pubmed: 33525959
Joulaei H, Shooshtarian S, Dianatinasab M. Is UNAIDS 90–90-90 Target a Dream or a Reality for Middle East and North Africa Region on ending the AIDS epidemic? A review study. AIDS Rev. 2019;20(2):772.
doi: 10.24875/AIDSRev.M18000020
UNAIDS Data, 2022. Available at: https://www.unaids.org/fr/regionscountries/countries/tunisia .
Lomelí-Martínez SM, González-Hernández LA, Ruiz-Anaya ADJ, Lomelí-Martínez MA, Martínez-Salazar SY, Mercado González JJ, et al. Oral manifestations associated with HIV/AIDS patients. Medicina. 2022;58:1214. https://doi.org/10.3390/medicina58091214 .
doi: 10.3390/medicina58091214
pubmed: 36143891
pmcid: 9504409
Olaniyi O Taiwo OO, Hassan Z. The impact of highly active antiretroviral therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria. AIDS Res Ther. 2010;7:19.
Nittayananta W, Talungchit S, Jaruratanasirikul S, Silpapojakul K, Chayakul P, Nilmanat A, et al. Effects of long-term use of HAART on oral health status of HIV infected subjects. J Oral Pathol Med. 2010;39(5):397–406. https://doi.org/10.1111/j.1600-0714.2009.00875.x .
doi: 10.1111/j.1600-0714.2009.00875.x
pubmed: 20202089
pmcid: 3217232
Umeizudike KA, Osagbemiro BB, Daramola OO, Adeyemo TA. Oral health related quality of life among HIV positive patients attending two HIV outpatient clinics in Nigeria - a cross sectional study. Afr Health Sci. 2021;21(2):566–75.
doi: 10.4314/ahs.v21i2.11
pubmed: 34795709
pmcid: 8568235
Ghiasvand H, Waye KM, Noroozi M, Harouni GG, Armoon B, Bayani A. Clinical determinants associated with quality of life for people who live with HIV/AIDS: a Meta-analysis. BMC Health Serv Res. 2019;19(1):768.
doi: 10.1186/s12913-019-4659-z
pubmed: 31665007
pmcid: 6819532
Khademi N, Zanganeh A, Saeidi S, Teimouri R, Khezeli M, Jamshidi B, et al. Quality of life of HIV-infected individuals: insights from a study of patients in Kermanshah. Iran BMC Infect Dis. 2021;21(1):203.
doi: 10.1186/s12879-021-05908-z
pubmed: 33622262
Mahajan PG, Kheur SM, Mahajan GD, Kheur M, Raj AT, Patil S, et al. Comparison of salivary total protein and electrolyte profile in HIV patients with and without antiretroviral therapy. Dis Mon. 2021;67(9): 101165. https://doi.org/10.1016/j.disamonth.2021.101165 .
doi: 10.1016/j.disamonth.2021.101165
pubmed: 33640174
Nizamuddin I, Koulen P, McArthur CP. Contribution of HIV infection, AIDS, and antiretroviral therapy to exocrine pathogenesis in salivary and lacrimal glands. Int J Mol Sci. 2018;19:2747. https://doi.org/10.3390/ijms19092747 .
doi: 10.3390/ijms19092747
pubmed: 30217034
pmcid: 6164028
Iorgulescu G. Saliva between normal and pathological. Important factors in determining systemic and oral health. J Med Life. 2009;2(3):303–7.
pubmed: 20112475
pmcid: 5052503
Cao P, Zhang Y, Dong G, Wu H, Yang Y, Liu Y. clinical oral condition analysis and the influence of highly active antiretroviral therapy on human salivary microbial community diversity in HIV-infected/AIDS patients. Front Cell Infect Microbiol. 2022;12:937039. https://doi.org/10.3389/fcimb.2022.937039 .
doi: 10.3389/fcimb.2022.937039
pubmed: 35846778
pmcid: 9277119
Shahar E, Pollack S, Kedem E, Hassoun G, Nagler R. Effect of HAART on salivary composition and oxidative profile in HIV infected patients. Curr HIV Res. 2008;6(5):447–51.
doi: 10.2174/157016208785861212
pubmed: 18855655
de Souza AJ, Gomes-Filho IS, da Silva CA, Passos-Soares JdS, da Cruz SS, Trindade SC, et al. Factors associated with dental caries, periodontitis and intra-oral lesions in individuals with HIV / AIDS. AIDS Care. 2018;30(5):578–85. https://doi.org/10.1080/09540121.2017.1400640 .
doi: 10.1080/09540121.2017.1400640
pubmed: 29124950
Acharya A, Muralidharan S, Mallaiah P, Geetha S. Dental caries prevalence among HIV adult population in India: a systematic review. J Oral Maxillofac Pathol. 2020;24:588.
doi: 10.4103/jomfp.JOMFP_64_20
pubmed: 33967519
Kalanzi D, Mayanja-Kizza H, Nakanjako D, Mwesigwa CL, Ssenyonga R, Amaechi BT. Prevalence and factors associated with dental caries in patients attending an HIV care clinic in Uganda: a cross sectional study. BMC Oral Health. 2019;19:159. https://doi.org/10.1186/s12903-019-0847-9 .
doi: 10.1186/s12903-019-0847-9
pubmed: 31324242
pmcid: 6642521
Murererehe J, Malele-Kolisa Y, Niragire F, Yengopal V. Prevalence of dental caries and associated risk factors among people living with HIV/AIDS and HIV uninfected adults at an HIV clinic in Kigali, Rwanda. PLoS ONE. 2023;18(4):e0276245. https://doi.org/10.1371/journal.pone.0276245 .
doi: 10.1371/journal.pone.0276245
pubmed: 37023108
pmcid: 10079010
Phelan JA, Mulligan R, Nelson E, Brunelle J, Alves MEAF, Navazesh M, et al. dental caries in HIV-seropositive women. J Dent Res. 2004;83(11):869–73. https://doi.org/10.1177/154405910408301109 . PMID: 15505238.
doi: 10.1177/154405910408301109
pubmed: 15505238
Rezaei-Soufi L, Davoodi P, Abdolsamadi HR, Jazaeri M, Malekzadeh H. Dental caries prevalence in human immunodeficiency virus infected patients receiving highly active anti-retroviral therapy in Kermanshah, Iran. Cell J. 2014;16(1):73–8. Epub 2014 Feb 3. PMID: 24518976; PMCID: PMC3933441.
pubmed: 24518976
pmcid: 3933441
Cherian AP, Jeftha A. Xerostomia and salivary flow rates in HIV patients. SADJ. 2017;72(2):62–7.
Biocina-Lukenda D, Blazić-Potocki Z, Lukenda J, Potocki-Karacić T. HIV infection, as opposed to antiretroviral therapy, does not cause changes in the concentration levels of specific salivary electrolytes. Coll Antropol. 2009;33(1):93–7. PMID: 19408610.
pubmed: 19408610
STROBE Checklist for cross-sectional studies. Available at: https://www.strobe.statement.org/ .
Krejcie RV, Morgan DW. Determining sample size for research activities. Educ Psychol Measur. 1970;30:607–10.
doi: 10.1177/001316447003000308
Varenne B. Mean number of decayed, missing and filled permanent teeth (mean DMFT) among the 12-year-old age group. Available at: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3812 .
Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res. 1992;71(7):1363–9.
doi: 10.1177/00220345920710070301
pubmed: 1629451
de Oliveira NC, de Oliveira TC, Klamas VC, Ventura MA, Kamei AA, Naka JY, et al. Salivary flow, amylase, and total protein in hospitalized patients with HIV infection / AIDS complications. Afr H Sci. 2020;20(2):597–604.
doi: 10.4314/ahs.v20i2.7
Mandal PK, Mitra M, Acharya S, Ghosh C, Mohanty S, Saha S. Salivary IgA versus HIV and Dental Caries. J Clin Diag Res. 2016;10(9):61–4.
Muralidharan S, Acharya A, Margabandhu S. Dentition status and treatment needs of human immunodeficiency virus-positive patients on antiretroviral therapy in Raichur taluk, Karnataka, India: a cross sectional study. Eur J Dent. 2017;11:238–41.
doi: 10.4103/ejd.ejd_290_16
pubmed: 28729800
pmcid: 5502572
Kumar S, Mishra P, Warhekar S, Airen B, Jain D, Godha S. Oral health status and oromucosal lesions in patients living with HIV/AIDS in India: A comparative study. AIDS Res Treat. 2014;2014:480247.
pubmed: 25215229
pmcid: 4158162
Arubaku W , Kwizera G , Tusubira D , Kanyesigye M , Chamut S, Seymour BA et al. Prevalence, correlates and treatment needs of dental caries among people on antiretroviral therapy in Uganda: a cross sectional study. BMC Oral Health. 2023;23–446. https://doi.org/10.1186/s12903-023-03156-y .
Berrezouga L, Kooli I, Marrakchi W, Belgacem S, Babba H, Ben Khelifa M et al. Quality of life of people living with HIV: a pilot study. J Dent Res. 2021;vol #100(Spec Iss_A). ID 2228. https://iadr.abstractarchives.com/abstract/21iags-3563202/quality-of-life-of-people-living-with-hiv-a-pilot-study .
World Health Organization. Global oral health status report towards universal health coverage for oral health by 2030. 2022. Available at: file:///C:/Users/001/Downloads/9789240061484-eng.pdf.
Utterwulghe S and Bouraoui Khouja A. Ten years after the Jasmine Revolution, it’s time for the Tunisian garden to bloom again. UNDP, January 15, 2021. https://www.undp.org/blog/ten-years-after-jasmine-revolution-its-time-tunisian-garden-bloom-again .
Johar N, Proctor GB, Kumar R. A comparative study of salivary composition of HIV seropositive patients on HAARTand not on HAART. J Indian Acad Oral Med Radiol. 2011;23:29–32.
doi: 10.5005/jp-journals-10011-1085
Lin AL, Johnson DA, Sims CA, Stephan KT, Yeh CK. Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(3):318–24.
doi: 10.1016/j.tripleo.2005.07.021
pubmed: 16920540
Palupi R, Sosiawan A, Wening GRS, Ramadhani A. Factors influencing dental caries in HIV/AIDS patients. Acta Medica Philippina. 2019;53(5):412–6.
doi: 10.47895/amp.v53i5.73
Escalona LA, Warner NA, Chaiyarit P, Gregory RL. Salivary IgA antibodies to gp120 from HIV+ and HIV- patients. Acta Odontol Venez. 2004;42(2):90–6.
Challacombe SJ, Sweet SP. Oral mucosal immunity and HIV infection: current status. Oral Dis. 2002;8(Suppl 2):55–62. https://doi.org/10.1034/j.1601-0825.2002.00013.x . PMID: 12164661.
doi: 10.1034/j.1601-0825.2002.00013.x
pubmed: 12164661
Lopez E, Shattock RJ, Kent SJ, Chung AW. The Multifaceted Nature of Immunoglobulin A. AIDS Res Hum Retroviruses. 2018;34(9). https://doi.org/10.1089/aid.2018.0099 .
Ahmadi-Motamayel F, Amjad SV, Goodarzi MT, Poorolajal J. Evaluation of salivary uric acid and pH in human immunodeficiency virus infected patients: a historical cohort study. Infect Disord Drug Targets. 2018;18(1):35–40. https://doi.org/10.2174/1871526517666170428122405 . PMID: 28462698.
doi: 10.2174/1871526517666170428122405
pubmed: 28462698